Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2023 -8.007M
March 31, 2023 -12.58M
December 31, 2022 -8.90M
September 30, 2022 -9.401M
June 30, 2022 -10.60M
March 31, 2022 -13.54M
December 31, 2021 -9.718M
September 30, 2021 -7.862M
June 30, 2021 -9.568M
March 31, 2021 -13.47M
December 31, 2020 -8.51M
September 30, 2020 -7.883M
June 30, 2020 -7.569M
March 31, 2020 -11.78M
December 31, 2019 -8.875M
September 30, 2019 -9.819M
June 30, 2019 -7.161M
March 31, 2019 -15.68M
December 31, 2018 16.36M
September 30, 2018 -6.991M
June 30, 2018 -4.826M
March 31, 2018 -9.255M
December 31, 2017 1.208M
September 30, 2017 -11.04M
June 30, 2017 -9.707M
Date Value
March 31, 2017 -17.18M
December 31, 2016 -20.97M
September 30, 2016 -35.09M
June 30, 2016 -46.43M
March 31, 2016 -51.87M
December 31, 2015 82.77M
September 30, 2015 -41.58M
June 30, 2015 -31.84M
March 31, 2015 -92.99M
December 31, 2014 -53.65M
September 30, 2014 238.24M
June 30, 2014 -23.32M
March 31, 2014 -43.56M
December 31, 2013 -36.47M
September 30, 2013 -26.39M
June 30, 2013 -25.75M
March 31, 2013 -25.30M
December 31, 2012 -36.09M
September 30, 2012 -30.40M
June 30, 2012 -2.431M
March 31, 2012 -11.22M
December 31, 2011 -8.554M
September 30, 2011 -6.924M
June 30, 2011 -8.491M
March 31, 2011 -9.139M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
MabCure, Inc. --
Adynxx, Inc. --
OncoSec Medical, Inc. --
Proteonomix, Inc. --
Rebus Holdings, Inc. --